The $100 Million Deal: Intuit and OpenAI Launch a New Era of Smart Finance

In the fast-evolving world of fintech, partnerships occasionally emerge that signal not just product expansion but an industry-level realignment. That is precisely the impression left by Intuit’s newly announced multi-year…

NewsTrackerToday

NewsTrackerToday is an international analytical media platform offering a deep and independent view of the events shaping the global economy, business, and technology landscape. We don’t just cover the news – we analyze the forces behind it.

Our team unites experienced journalists and analysts specializing in economics, finance, corporate strategy, and global markets. Every article is based on verified data, independent research, and professional expertise.

At NewsTrackerToday, accuracy, objectivity, and analytical depth come first. We identify trends, forecast shifts, and provide readers with tools to make informed decisions in an unpredictable environment.

Our core focus areas include macroeconomics, business, technology, and investments. We track how global trends influence local markets, industries, and individual investors.

NewsTrackerToday is more than media – it’s a reliable compass in an ever-changing information world.

Top News

From Bets to Markets: The Trillion-Dollar Prediction Play

Prediction markets are rapidly moving from a niche experiment into a mainstream financial-adjacent product, and recent projections suggest the scale…

Amazon to cut nearly 30K corporate jobs in largest layoff in company history: report

Amazon is planning to cut nearly 10% of its corporate workforce beginning…

An Italian Probe-Card Maker Is Up 330%. It Might Still Be Cheap.

Technoprobe SpA, a family-controlled Italian manufacturer with more than 3,000 employees, has…

Formula E Isn’t Just Racing – It Just Triggered an EV Revolution

Formula E enters its new season not just as a racing spectacle,…

Billions on the Line: Pfizer vs Novo in a Fight for the Drug That Could Change Everything

The weight-loss drug market has reached a stage where corporate moves matter…